Authors:
Rozemuller, EH
Kropveld, A
Kreyveld, E
Leppers, FGJ
Scheidel, KC
Slootweg, PJ
Tilanus, MGJ
Citation: Eh. Rozemuller et al., Sensitive detection of p53 mutation: Analysis by direct sequencing and multisequence analysis, CANCER DET, 25(2), 2001, pp. 109-116
Authors:
Wu, S
Shiao, YM
Lai, CY
Lai, SM
Chen, SP
SIdebottom, DA
Hildebrand, WH
Tilanus, MGJ
Chou, FC
Tsai, MF
Citation: S. Wu et al., Polymorphism of human HLA-DRB1 antigens generated by genetic exchange between DR2 (DRB115011) and DR6 (DRB1*1405) alleles: a novel DRB1 allele (DRB1*1437) identified in a Paiwan tribe member of Taiwan, TISSUE ANTI, 57(4), 2001, pp. 384-387
Authors:
Bijlsma, FJ
Bruggink, AH
Hartman, M
Gmelig-Meyling, FHJ
Tilanus, MGJ
de Jonge, N
de Weger, RA
Citation: Fj. Bijlsma et al., No association between IL-10 promoter gene polymorphism and heart failure or rejection following cardiac transplantation, TISSUE ANTI, 57(2), 2001, pp. 151-153
Authors:
Baselmans, PJ
Pollabauer, EM
van Reijsen, FC
Heystek, HC
Hren, A
Stumptner, P
Tilanus, MGJ
Vooijs, WC
Mudde, GC
Citation: Pj. Baselmans et al., IgE production after antigen-specific and cognate activation of HLA-DPw4-restricted T-cell clones, by 78% of randomly selected B-cell donors, HUMAN IMMUN, 61(8), 2000, pp. 789-798
Authors:
de Weger, RA
Tilanus, MGJ
Scheidel, KC
van den Tweel, JG
Verdonck, LF
Citation: Ra. De Weger et al., Monitoring of residual disease and guided donor leucocyte infusion after allogeneic bone marrow transplantation by chimaerism analysis with short tandem repeats, BR J HAEM, 110(3), 2000, pp. 647-653
Citation: Bpl. Wijnhoven et al., Human oesophageal adenocarcinoma cell lines JROECL 47 and JROECL 50 are admixtures of the human colon carcinoma cell line HCT 116, BR J CANC, 82(9), 2000, pp. 1510-1512
Authors:
Voorter, CEM
Tilanus, MGJ
van den Berg-Loonen, EM
Citation: Cem. Voorter et al., Two new HLA DPB1 alleles identified by sequence-based typing: DPB18201 and DPB1*8301, TISSUE ANTI, 56(6), 2000, pp. 560-562
Authors:
Tjebbes, GWA
Van der Straat, FGJL
Tilanus, MGJ
Hordijk, GJ
Slootweg, PJ
Citation: Gwa. Tjebbes et al., p53 tumor suppressor gene as a clonal marker in head and neck squamous cell carcinoma: p53 mutations in primary tumor and matched lymph node metastases, ORAL ONCOL, 35(4), 1999, pp. 384-389
Authors:
Visser, CJT
Tilanus, MGJ
Tatari, Z
van der Zwan, AW
Bakker, R
Rozemuller, EH
Schaeffer, V
Tamouza, R
Charron, D
Citation: Cjt. Visser et al., Sequencing-based typing of MICA reveals 33 alleles: a study on linkage with classical HLA genes, IMMUNOGENET, 49(6), 1999, pp. 561-566
Authors:
Kropveld, A
Rozemuller, EH
Leppers, FGJ
Scheidel, KC
de Weger, RA
Koole, R
Hordijk, GJ
Slootweg, PJ
Tilanus, MGJ
Citation: A. Kropveld et al., Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers, LAB INV, 79(3), 1999, pp. 347-353
Authors:
Scheltinga, SA
van der Zwan, AW
Mongkolsuk, T
Sujirachato, K
Chiewsilp, P
Tilanus, MGJ
Citation: Sa. Scheltinga et al., Characterization of a novel HLA-A2 variant, A02012, in the Southern Thai-Muslin population, TISSUE ANTI, 53(5), 1999, pp. 507-509
Authors:
Verdonck, LF
Petersen, EJ
Lokhorst, HM
Nieuwenhuis, HK
Dekker, AW
Tilanus, MGJ
de Weger, RA
Citation: Lf. Verdonck et al., Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor Tcells, BONE MAR TR, 22(11), 1998, pp. 1057-1063